BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8955 related articles for article (PubMed ID: 2432832)

  • 1. Regulation of the antigenic phenotype of human melanoma cells by recombinant interferons.
    Giacomini P; Gambari R; Barbieri R; Nisticò P; Tecce R; Pestka S; Gustafsson K; Natali PG; Fisher PB
    Anticancer Res; 1986; 6(5):877-84. PubMed ID: 2432832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells.
    Nisticò P; Tecce R; Giacomini P; Cavallari A; D'Agnano I; Fisher PB; Natali PG
    Cancer Res; 1990 Dec; 50(23):7422-9. PubMed ID: 1701342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation by interferons of HLA antigen, high-molecular-weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential.
    Maio M; Gulwani B; Langer JA; Kerbel RS; Duigou GJ; Fisher PB; Ferrone S
    Cancer Res; 1989 Jun; 49(11):2980-7. PubMed ID: 2497970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
    Shaw AR; Chan JK; Reid S; Seehafer J
    J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of recombinant human fibroblast interferon and mezerein on growth, differentiation, immune interferon binding and tumor associated antigen expression in human melanoma cells.
    Fisher PB; Hermo H; Solowey WE; Dietrich MC; Edwalds GM; Weinstein IB; Langer JA; Pestka S; Giacomini P; Kusama M
    Anticancer Res; 1986; 6(4):765-74. PubMed ID: 2944474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation by recombinant DNA leukocyte (alpha) and fibroblast (beta) interferons of the expression and shedding of HLA- and tumor-associated antigens by human melanoma cells.
    Giacomini P; Aguzzi A; Pestka S; Fisher PB; Ferrone S
    J Immunol; 1984 Sep; 133(3):1649-55. PubMed ID: 6747299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
    Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
    J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical analysis of the modulation of human melanoma-associated antigens by DNA recombinant immune interferon.
    Giacomini P; Imberti L; Aguzzi A; Fisher PB; Trinchieri G; Ferrone S
    J Immunol; 1985 Oct; 135(4):2887-94. PubMed ID: 3928760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters.
    Leon JA; Mesa-Tejada R; Gutierrez MC; Estabrook A; Greiner JW; Schlom J; Fisher PB
    Anticancer Res; 1989; 9(6):1639-47. PubMed ID: 2516715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon.
    Ziai MR; Imberti L; Tongson A; Ferrone S
    Cancer Res; 1985 Nov; 45(11 Pt 2):5877-82. PubMed ID: 3931909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of class II MHC gene expression by interferons: insights into the mechanism of action of interferon (review).
    Giacomini P; Fisher PB; Duigou GJ; Gambari R; Natali PG
    Anticancer Res; 1988; 8(6):1153-61. PubMed ID: 2464333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential in vitro effects of recombinant alpha-interferon and recombinant gamma-interferon alone or in combination on the expression of melanoma-associated surface antigens.
    Murray JL; Stuckey SE; Pillow JK; Rosenblum MG; Gutterman JU
    J Biol Response Mod; 1988 Apr; 7(2):152-61. PubMed ID: 3129542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.
    Carrel S; Schmidt-Kessen A; Giuffrè L
    Eur J Immunol; 1985 Feb; 15(2):118-23. PubMed ID: 3918869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human IFN-gamma, but not IFN-alpha or IFN-beta, enhances MHC- and non-MHC-encoded glycoproteins by a protein synthesis-dependent mechanism.
    Giacomini P; Tecce R; Gambari R; Sacchi A; Fisher PB; Natali PG
    J Immunol; 1988 May; 140(9):3073-81. PubMed ID: 3129509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of receptors, cell surface antigens, and proteins in human melanoma cell lines resistant to human recombinant beta- or gamma-interferon.
    Gomi K; Akinaga S; Oka T; Morimoto M
    Cancer Res; 1986 Dec; 46(12 Pt 1):6211-6. PubMed ID: 2430691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
    Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
    Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of class I major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection.
    Andrews PW; Trinchieri G; Perussia B; Baglioni C
    Cancer Res; 1987 Feb; 47(3):740-6. PubMed ID: 3026615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
    Muczynski KA; Anderson SK; Pious D
    J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen presentation by human monocytes: effects of modifying major histocompatibility complex class II antigen expression and interleukin 1 production by using recombinant interferons and corticosteroids.
    Rhodes J; Ivanyi J; Cozens P
    Eur J Immunol; 1986 Apr; 16(4):370-5. PubMed ID: 2422040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential susceptibility to recombinant interferon-gamma-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma.
    Anichini A; Castelli C; Sozzi G; Fossati G; Parmiani G
    J Immunol; 1988 Jan; 140(1):183-91. PubMed ID: 3121738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 448.